REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 49 filers reported holding REGULUS THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $3,000 | – | 4,500 | +49900.0% | 0.00% | – |
| Q4 2017 | $0 | – | 9 | +800.0% | 0.00% | – |
| Q3 2017 | $0 | – | 1 | -75.0% | 0.00% | – |
| Q2 2017 | $0 | – | 4 | +100.0% | 0.00% | – |
| Q1 2017 | $0 | – | 2 | -81.8% | 0.00% | – |
| Q4 2016 | $0 | – | 11 | -31.2% | 0.00% | – |
| Q3 2016 | $0 | – | 16 | -77.5% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 71 | -34.9% | 0.00% | – |
| Q4 2015 | $1,000 | – | 109 | +43.4% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 76 | -3.8% | 0.00% | – |
| Q2 2015 | $1,000 | 0.0% | 79 | +11.3% | 0.00% | – |
| Q1 2015 | $1,000 | -66.7% | 71 | -58.5% | 0.00% | – |
| Q4 2014 | $3,000 | +50.0% | 171 | -34.2% | 0.00% | – |
| Q2 2014 | $2,000 | – | 260 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
| Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
| ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
| Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
| Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
| Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
| DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
| ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |